FMO5 and aortic aneurysm: These decreasedcapacities, which also occur in aortic aneurysm patients, may need to increase theduration of the activity of NADPH oxidase enzymes in phagocytic cells and itsisomers in non-phagocytic cells, especially NOXs in vascular endothelium.